SEDE LEGALE ED AMMINISTRATIVA HEADQUARTERS Cefla s.c. Via Selice Provinciale, 23/a - 40026 Imola - BO (Italy) tel. +39 0542 653111 - fax +39 0542 653344 RX DC STABILIMENTO PLANT Via Bicocca, 14/c - 40026 Imola - BO (Italy) tel. +39 0542 653441 - fax +39 0542 653555 CEFLA NORTH AMERICA 6125 Harris Technology Blvd. Charlotte, NC 28269 - U.S.A. Toll Free: (+1) 800.416.3078 Fax: (+1) 704.631.4609 The images and technical specifications shown in this catalog are for indicative purposes only. As part of ongoing technological updates, technical specifications may be subject to changes without prior notice. In accordance with current regulations, in non-EU areas some products, as well as certain technical specifications, may have different availability and configurations. We encourage you to always contact your local distributor for up-to-date technical specifications, availability and configurations. MRXDGB251S00

HIGHEST QUALITY WITH LOWEST EXPOSURE Always-sharp images, versatility and meticulous attention to patient health. With RX DC you get the best DC technology with the lowest X-ray dose. The constant potential high frequency generator (DC) provides sharp images with the very highest level of detail. Compared to AC systems, they also reduce exposure times and the amount of harmful radiation by containing the dose administered to the patient. A focal spot of just 0.4 mm - one of the smallest available - ensures images are always sharp and of the highest quality. SUB-OPTIMAL DEFINITION OPTIMAL DEFINITION...

Superb image definition: sharp edges and excellent detail. An embedded collimator cone gives a source-to-skin distance of 30 cm. This increases X-ray parallelism, providing more precise images, lower doses and ensuring greater attention to patient health. RX DC offers maximum flexibility and optimum X-ray quality whatever the type of sensor connected. IMMEDIATE CONFIGURATION Multi-Mode automatic exposure parameter modulation always ensures optimal time and power selection. Parameters are, in fact, adjusted automatically according to patient build and the region under investigation. PRECISION...

(*) values depend on the country where the product is marketed.